Linda Burkly, EVP, Chief Scientific Officer at Editas Medicine, sold EDIT on Jul 28, 2026
Data as of Oct 16
▼ SELL$13.2K4,928 shares at $2.67Linda Burkly EVP, Chief Scientific OfficerEDIT Editas Medicine, Inc.
- Traded
- Jul 28, 2026
- Disclosed
- Jul 29, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
EDIT since disclosure
−9.6%
after the sale
Similar stocks (SPY) since disclosure
+4.6%
S&P 500 (SPY)
Change in closing price from Jul 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.